Thoratec Presentation at Lehman Brothers Conference to Be Webcast
16 March 2007 - 12:30AM
PR Newswire (US)
PLEASANTON, Calif., March 15 /PRNewswire-FirstCall/ -- Thoratec
Corporation (NASDAQ:THOR), a world leader in products to treat
cardiovascular disease, said today that it will be participating in
the Lehman Brothers 10th Annual Global Healthcare Conference on
Wednesday, March 21. Gary F. Burbach, president and chief executive
officer, will provide an update on the company, beginning at 10:15
a.m., Eastern Daylight Time (7:15 a.m., Pacific Daylight Time). The
presentation will be available through the conference website at
http://cc.talkpoint.com/LEHM002/031907a_jw/default.asp?entity=Thoratec,
and on the company's website at http://www.thoratec.com/. Thoratec
is a world leader in therapies to address advanced-stage heart
failure. The company's product lines include the Thoratec(R) VAD
(Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular
Assist System) with more than 11,000 devices implanted in patients
suffering from heart failure. Additionally, its International
Technidyne Corporation (ITC) division supplies blood testing and
skin incision products. Thoratec is headquartered in Pleasanton,
California. For more information, visit the company's web sites at
http://www.thoratec.com/ or http://www.itcmed.com/ TNR-437
DATASOURCE: Thoratec Corporation CONTACT: David Smith, Executive
Vice President, Chief Financial Officer of Thoratec Corporation,
+1-925-847-8600; or Neal Rosen of Kalt Rosen & Co.,
+1-415-397-2686 Web site: http://www.thoratec.com/
Copyright
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Synthorx Inc (NASDAQ): 0 recent articles
More Thoratec (MM) News Articles